AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?

Amgen’s AMGN stock has risen 13.5% so far this year compared with an increase of 1.6% for the industry. The stock has also outperformed the sector and S&P 500 Index, as seen in the chart below.AMGN Stock Outperforms Industry, Sector & S&P 500Image Source: Zacks Investment ResearchAmgen’s key medicines like...